EAM
KURA icon

Eagle Asset Management’s Kura Oncology KURA Stock Holding History

Eagle Asset Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-375,493
Closed -$4.59M – 552
2023
Q1 		$4.59M Sell
375,493
-32,007
-8% -$399K 0.03% 352
2022
Q4 		$4.91M Sell
407,500
-313,138
-43% -$4.55M 0.03% 339
2022
Q3 		$9.84M Sell
720,638
-21,689
-3% -$335K 0.06% 241
2022
Q2 		$13.6M Sell
742,327
-28,562
-4% -$411K 0.09% 211
2022
Q1 		$12.4M Buy
770,889
+33,470
+5% +$483K 0.06% 244
2021
Q4 		$10.5M Sell
737,419
-63,435
-8% -$1.03M 0.05% 302
2021
Q3 		$15M Sell
800,854
-359
-0% -$6.76K 0.07% 246
2021
Q2 		$16.7M Sell
801,213
-43,977
-5% -$1.09M 0.07% 257
2021
Q1 		$24.8M Buy
845,190
+55,226
+7% +$1.75M 0.11% 220
2020
Q4 		$25.8M Sell
789,964
-713,487
-47% -$25.1M 0.15% 200
2020
Q3 		$45.9M Sell
1,503,451
-501,002
-25% -$11.1M 0.24% 151
2020
Q2 		$33.3M Sell
2,004,453
-42,531
-2% -$614K 0.19% 174
2020
Q1 		$20.4M Sell
2,046,984
-14,693
-0.7% -$168K 0.13% 206
2019
Q4 		$28.3M Sell
2,061,677
-14,070
-0.7% -$208K 0.14% 211
2019
Q3 		$31.5M Buy
2,075,747
+31,878
+2% +$567K 0.16% 194
2019
Q2 		$40.2M Sell
2,043,869
-4,839
-0.2% -$80.3K 0.21% 180
2019
Q1 		$34M Buy
2,048,708
+14,317
+0.7% +$221K 0.18% 198
2018
Q4 		$28.6M Sell
2,034,391
-36,026
-2% -$477K 0.18% 201
2018
Q3 		$36.2M Buy
2,070,417
+703,282
+51% +$13.5M 0.18% 199
2018
Q2 		$24.9M Buy
+1,367,135
New +$23.2M 0.13% 220

Other funds holding KURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Eagle Asset Management's KURA Position: Q2 2023 in Review

Eagle Asset Management sold out of Kura Oncology (KURA) in Q2 2023, closing a stake of 375,493 shares — an estimated $4.59M sold.

Eagle Asset Management first reported a position in KURA in Q2 2018 and held it in 20 quarters. The position peaked at $45.9M in Q3 2020. 148 funds tracked by Wall St. Rank hold KURA as of Q2 2023.

  • Eagle Asset Management reported no remaining Kura Oncology position as of Q2 2023 after selling out during the quarter.
  • Eagle Asset Management sold 375,493 Kura Oncology shares in Q2 2023, an estimated $4.59M.
  • Eagle Asset Management first reported a position in Kura Oncology in Q2 2018 and held it in 20 quarters.
  • Eagle Asset Management's Kura Oncology position peaked at $45.9M in Q3 2020.
  • 148 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2023.

Based on Eagle Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.